| Glycine transporter inhibitors: A new avenue for managing neuropathic pain M Al-Khrasani, A Mohammadzadeh, M Balogh, K Király, S Barsi, B Hajnal, ... Brain Research Bulletin 152, 143-158, 2019 | 35 | 2019 |
| The peripheral versus central antinociception of a novel opioid agonist: Acute inflammatory pain in rats M Balogh, ZS Zádori, B Lázár, D Karádi, S László, SA Mousa, S Hosztafi, ... Neurochemical Research 43, 1250-1257, 2018 | 27 | 2018 |
| Angiotensin receptors and neuropathic pain M Balogh, C Aguilar, NT Nguyen, AJ Shepherd Pain reports 6 (1), e869, 2021 | 26 | 2021 |
| A comprehensive time course and correlation analysis of indomethacin-induced inflammation, bile acid alterations and dysbiosis in the rat small intestine B Lázár, SB László, B Hutka, AS Tóth, A Mohammadzadeh, E Berekméri, ... Biochemical Pharmacology 190, 114590, 2021 | 25 | 2021 |
| New morphine analogs produce peripheral antinociception within a certain dose range of their systemic administration E Lackó, P Riba, Z Giricz, A Váradi, L Cornic, M Balogh, K Király, ... Journal of Pharmacology and Experimental Therapeutics 359 (1), 171-181, 2016 | 23 | 2016 |
| Efficacy-based perspective to overcome reduced opioid analgesia of advanced painful diabetic neuropathy in rats M Balogh, F Zádor, ZS Zádori, M Shaqura, K Király, A Mohammadzadeh, ... Frontiers in Pharmacology 10, 347, 2019 | 21 | 2019 |
| On the role of peripheral sensory and gut mu opioid receptors: Peripheral analgesia and tolerance S Fürst, ZS Zádori, F Zádor, K Király, M Balogh, SB László, B Hutka, ... Molecules 25 (11), 2473, 2020 | 20 | 2020 |
| A new potent analgesic agent with reduced liability to produce morphine tolerance K Kiraly, FF Caputi, A Hanuska, E Kató, M Balogh, L Köles, M Palmisano, ... Brain research bulletin 117, 32-38, 2015 | 19 | 2015 |
| Effects of articaine on [3H] noradrenaline release from cortical and spinal cord slices prepared from normal and streptozotocin-induced diabetic rats and compared to lidocaine D Végh, A Somogyi, D Bányai, M Lakatos, M Balogh, M Al-Khrasani, ... Brain Research Bulletin 135, 157-162, 2017 | 17 | 2017 |
| Pharmacological evidence on augmented antiallodynia following systemic co-treatment with GlyT-1 and GlyT-2 inhibitors in rat neuropathic pain model A Mohammadzadeh, PP Lakatos, M Balogh, F Zádor, DÁ Karádi, ... International Journal of Molecular Sciences 22 (5), 2479, 2021 | 15 | 2021 |
| Comparisons of In Vivo and In Vitro Opioid Effects of Newly Synthesized 14-Methoxycodeine-6-O-sulfate and Codeine-6-O-sulfate F Zádor, A Mohammadzadeh, M Balogh, ZS Zádori, K Király, S Barsi, ... Molecules 25 (6), 1370, 2020 | 12 | 2020 |
| New opioid receptor antagonist: Naltrexone-14-O-sulfate synthesis and pharmacology AKM Zádor F, Király K, Váradi A, Balogh M, Fehér Á, Kocsis D, Erdei AI ... European Journal of Pharmacology, 2017 | 11 | 2017 |
| Chronic treatment with rofecoxib but not ischemic preconditioning of the myocardium ameliorates early intestinal damage following cardiac ischemia/reperfusion injury in rats SB László, B Lázár, GB Brenner, A Makkos, M Balogh, M Al-Khrasani, ... Biochemical Pharmacology 178, 114099, 2020 | 9 | 2020 |
| 14-O-Methylmorphine: a novel selective mu-opioid receptor agonist with high efficacy and affinity F Zádor, M Balogh, A Váradi, ZS Zádori, K Király, E Szűcs, B Varga, ... European Journal of Pharmacology 814, 264-273, 2017 | 9 | 2017 |
| Similarity and dissimilarity in antinociceptive effects of dipeptidyl-peptidase 4 inhibitors, Diprotin A and vildagliptin in rat inflammatory pain models following spinal … M Balogh, BK Varga, DÁ Karádi, P Riba, Z Puskár, M Kozsurek, ... Brain Research Bulletin 147, 78-85, 2019 | 8 | 2019 |
| Sensory neuron dysfunction in orthotopic mouse models of colon cancer M Balogh, J Zhang, CM Gaffney, N Kalakuntla, NT Nguyen, RT Trinh, ... Journal of neuroinflammation 19 (1), 204, 2022 | 7 | 2022 |
| Shedding light on the pharmacological interactions between μ-opioid analgesics and angiotensin receptor modulators: A new option for treating chronic pain K Király, DÁ Karádi, F Zádor, A Mohammadzadeh, AR Galambos, ... Molecules 26 (20), 6168, 2021 | 7 | 2021 |
| Lack of small intestinal dysbiosis following long-term selective inhibition of cyclooxygenase-2 by rofecoxib in the rat B Lázár, GB Brenner, A Makkos, M Balogh, SB László, M Al-Khrasani, ... Cells 8 (3), 251, 2019 | 7 | 2019 |
| Targeting neuroimmune interactions in diabetic neuropathy with nanomedicine M Balogh, JM Janjic, AJ Shepherd Antioxidants & redox signaling 36 (1-3), 122-143, 2022 | 5 | 2022 |
| Biochemical and pharmacological characterization of three opioid-nociceptin hybrid peptide ligands reveals substantially differing modes of their actions AI Erdei, A Borbély, A Magyar, N Taricska, A Perczel, O Zsíros, G Garab, ... Peptides 99, 205-216, 2018 | 5 | 2018 |
Zoltán S. ZádoriAssociate Professor, Semmelweis University, Department of Pharmacology and PharmacotherapyE-mail megerősítve itt: med.semmelweis-univ.hu
